1 / 19

The Johns Hopkins University Advanced Genomics & Genetics Analysis AS410.713.81.SU12

Analysis of Experiment E-GEOD-29989: Alternative Splicing of Exons in Human Hematopoietic Stem cells. The Johns Hopkins University Advanced Genomics & Genetics Analysis AS410.713.81.SU12 Phillip Woolwine. Outline. Alternative splicing of exons (ASE)

jalene
Download Presentation

The Johns Hopkins University Advanced Genomics & Genetics Analysis AS410.713.81.SU12

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Analysis of Experiment E-GEOD-29989: Alternative Splicing of Exons in Human Hematopoietic Stem cells The Johns Hopkins University Advanced Genomics & Genetics Analysis AS410.713.81.SU12 Phillip Woolwine

  2. Outline • Alternative splicing of exons (ASE) • ASE probed w/ AffymetrixGeneChip Exon array • Data analyzed w/ Affymetrix Power Tools (APT), R & Bioconductor • ASE during lineage-specific hematopoietic differentiation

  3. Background • ASE leads to mRNAs that can have similar or different functions/products and is a basis for functional diversity in gene expression • Includes exon skipping, mutually exclusive exons, alternative 5' donor sites, alternative 3' donor sites, and/or intron retention • ASE is believed to be a major player in lineage-specific differentiation of blood cells • Aberrant ASE can lead to leukemias, lymphomas, etc • Understanding of ASE events and the exome profile will benefit understanding of disease pathogenesis and aid in therapies

  4. Methods • Data retrieved from Experiment E-GEOD-29989 by Lui et al (2011) • AffymetrixGeneChip Human Exon 1.0 ST array • Transcriptional profile of lineage-specific differentiation of CD34 cells into • Erythropoietic (E), Granulopoietic (G), and Megakaryopoietic (M) cells • Data normalized with APT 1.14.2 • PCA outlier analysis in R and Bioconductor • Filtered by DABG p-val > 0.05 in >50% of classes • T-test used to determine exon enrichment/depletion by p-val & fold change (FC) • Evidence for alternative splicing verified in Ensembl • Top exon probes mapped to genes and differential expression plotted • green plots are CD34, red plots are lineage-specific • DAVID pathway analysis

  5. Results PCA of exon probes • Exon arrays are clustered along cell lineages; no outliers • G & E lineage more similar than M lineage

  6. Results Scree plot of exon probes • Approx. 70% of variability is explained in the first two eigenvectors

  7. Results Filtering and Testing Correction • Filter on DABG of all class types removed ~83,000 low intensity probes • mRNA filters may be more sensitive in some cases (table1, Della Beffa et al, 2008) • Other filtering included using core probesets in APT (core,ps, core.mps) • 197,245 probes remained after statistical tests • Potential for false positives (FP) though multiple testing correction not performed • At p-val <0.01 & FC > |1.5|there were 6413 in E, 3316 in G, 9638 in M; possible high FP • It can be argued that FWER is too conservative for the high-dimensionality of exon data ; • the tests may not necessarily be independent nor uniform in a non-significant way and FDR may not be appropriate (Della Beffa et al, 2008) • Proper pre-filtering of probes and true splice sites is a better strategy to limit FP

  8. Results One Significant ASE Transcript Cluster Common to All 3 Lineages • Dimensionality reduction at p-val < 0.00001 & FC >|2| • IGHA2 immunoglobulin heavy constant alpha 2

  9. Results Significant ASE in Erythropoieticvs CD34 • Dimensionality reduction at p-val < 0.00001 & FC >|2| • 20 unique transcript clusters ordered by p-val

  10. Results Significant ASE in Erythropoieticvs CD34 Genes and Pathways • DAVID Functional Annotation reveals enrichment for alternative splicing

  11. Results Significant ASE in Granulopoieticvs CD34 • Dimensionality reduction at p-val < 0.00001 & FC >|2| • 9 unique transcript clusters ordered by p-val

  12. Results Significant ASE in Granulopoieticvs CD34 Genes & Pathways • DAVID Functional Annotation reveals significant enrichment for signaling • Clusters include alternative splicing

  13. Results Significant ASE in Megakaryopoieticvs CD34 • Dimensionality reduction at p-val < 0.00001 & FC >|2| • 37 unique transcript clusters ordered by p-val

  14. Results Significant ASE in Megakaryopoieticvs CD34 Genes & Pathways • DAVID Functional Annotation reveals enrichment for alternative splicing & signaling (Several categories not shown but include those for immune system development)

  15. Results Top Significantly Upregulated ASE in Erythropoietic • P-val < 0.01 & FC >2 in Erythropoietic; P-val < 0.01 & FC < 1.5 in G & M lineages • Top upregulated exon probe 2527682; cluster id 2527672; gene PKND Significantly downregulated in Megakaryopoietic lineage

  16. Results Top Significantly Upregulated ASE in Granulopoietic • P-val < 0.01 & FC >2 in Granulopoietic; P-val < 0.01 & FC < 1.5 in E & M lineages • Top upregulated exon probe 4016430, 4016431; cluster id 4016428; gene BEX2 Significantly reduced expression versus CD34 in Erythropoietic lineage Significantly reduced expression versus CD34 in Megakaryopoietic lineage

  17. Results Top Significantly Upregulated ASE in Megakaryopoietic • P-val < 0.01 & FC >2 in Megakaryopoietic; P-val < 0.01 & FC < 1.5 in E & G lineages • Top upregulated exon probe 3275248; cluster id 3275132; gene GDI2 downregulated downregulated upregulated

  18. Discussion • ASE occurs during lineage-specific hematopoietic differentiation of CD34 cells into Erythropoietic, Granulopoietic, and Megakaryopoietic cells • Pathway terms are significantly enriched in alternative splicing and signaling, including those for immune system development, consistent with known biology • Relatively increased ASE in megakaryopoietic differentiation may suggest increased transcriptional complexity during development • Comparison to original research results by Lui et al (2011) share a few top hits and similar pathway enrichment • However, most top genes were not identical and is probably due to their use of the ExonSVD model for statistical assessment of exon enrichment/depletion • High number of significant hits at p< 0.01 may indicate high FDR and may warrant further filtering and dimensionality reduction • May be interesting to combine MiDAS and Rank Product for testing and correction

  19. References • Della Beffa et al (2008) Dissecting an alternative splicing analysis workflow for GeneChip Exon 1.0 ST Affymetrix arrays. BMC Genomics 9:571, PMID:19040723 • EBI (2012) Ensembl Genome Browser, release 68.<online> Available at: < http://useast.ensembl.org/index.html >[Access 8/20/12] • Higgs, B (2012) Advanced Genomics & Genetics Analysis, Lecture 2: Analysis and interpretation of splice variants. Johns Hopkins University, unpublished • Lui et al (2011) Transcriptome Profiling and Sequencing of differentiated Human Hematopoietic Stem cells Reveal Lineage Specific Expression and Alternative Splicing of Genes, Physiol Genomics 43(20):1117-34, PMID: 21828245 • NIAID/NIH (2012) DAVID Bioinformatics Resources 6.7: Functional Annotation Tool. <online> Available at:< http://david.abcc.ncifcrf.gov/tools.jsp >[Accessed 8/20/12]

More Related